The DOI matches its Crossref record.
A Randomized Trial of Single- and Two-Dose Ivermectin versus Thiabendazole for Treatment of Strongyloidiasis
Abstract
A randomized trial is described comparing ivermectin and thiabendazole for treatment of chronic infection with Strongyloides stercoralis. Subjects received ivermectin (200 micrograms/kg) in a single dose, ivermectin (200 micrograms/kg) on 2 consecutive days, or thiabendazole (50 mg/kg/day) twice daily for 3 consecutive days. Most subjects (94%) had intermittent symptoms, including urticaria, epigastric pain, and diarrhea. Stools were examined 7 days and 1, 3, 6, 10, and 22 months after treatment. Fifty-three subjects completed at least 3 months of follow-up. Only 1 of 34 and 2 of 19 ivermectin and thiabendazole subjects, respectively, had a stool positive for larvae after treatment. Symptoms were relieved in all 3 groups and eosinophil levels returned to normal in 90% of all subjects by 12 months. Nearly 95% of thiabendazole subjects had short-term adverse effects during therapy versus only 18% of those treated with ivermectin. One dose of ivermectin provides safety and efficacy equivalent to thiabendazole with a much lower prevalence of side effects and, consequently, better compliance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Grove, D. I. (1996) · Advances in Parasitology · doi:10.1016/s0065-308x(08)60036-6 · Cited by 309
Strongyloidiasis—An Insight into Its Global Prevalence and Management
Puthiyakunnon, S., Boddu, S., Li, Y., Zhou, X., Wang, C., Li, J., & Chen, X. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003018 · Cited by 302
The Drugs We Have and the Drugs We Need Against Major Helminth Infections
Keiser, J., & Utzinger, J. (2010) · Advances in Parasitology · doi:10.1016/s0065-308x(10)73008-6 · Cited by 288
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection
Henriquez-Camacho, C., Gotuzzo, E., Echevarria, J., White Jr, A. C., Terashima, A., Samalvides, F., Pérez-Molina, J. A., & Plana, M. N. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007745.pub3 · Cited by 193
Metadata
- Authors
- Gann, P. H., Neva, F. A., & Gam, A. A.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-05
- Volume
- 169
- Issue
- 5
- Pages
- 1076-1079
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2057078530
- Cited by
- 220
- References
- 0
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Randomized Trial of Single- and Two-Dose Ivermectin versus Thiabendazole for Treatment of Strongyloidiasis. https://app.cochat.ai/papers/10.1093/infdis/169.5.1076
- The paper
- Gann, P. H., Neva, F. A., & Gam, A. A. (1994). A Randomized Trial of Single- and Two-Dose Ivermectin versus Thiabendazole for Treatment of Strongyloidiasis. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/169.5.1076
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.